← Back to Search

You℞ Decision prescribing platform for Implementation Science (IMPROV Trial)

N/A
Waitlist Available
Led By Courtney Peasant Bonner, PhD
Research Sponsored by RTI International
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 months follow-up
Awards & highlights

IMPROV Trial Summary

This trial will test a new training to reduce stigma around prescribing mental health medication and naltrexone for alcohol use disorder, in order to increase providers' self-efficacy in prescribing these treatments.

Eligible Conditions
  • Implementation Science
  • Substance Use Disorder
  • Mental Health Disorders
  • Stigmatization

IMPROV Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 months follow-up
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 months follow-up for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Clinic Staff-Level Outcome: Acceptability of Stigma Reduction Training
Clinic Staff-Level Outcome: Observed Stigma Reduction
Clinic-Level Outcome: Adoption of Psychiatric Medication and Naltrexone
+7 more

IMPROV Trial Design

2Treatment groups
Experimental Treatment
Group I: YouRx Prescribing Platform OnlyExperimental Treatment1 Intervention
Staff working in the clinic in this arm will not be offered a whole-site stigma reduction training. However, staff will be offered this training at the conclusion of the study. Participating HIV care providers will have access to the YouRx Prescribing Platform.
Group II: Stigma-Reduction Training Arm + YouRx Prescribing PlatformExperimental Treatment2 Interventions
Staff working in the clinic in this arm will be offered a whole-site stigma reduction training. Participating HIV care providers will have access to the YouRx Prescribing Platform.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Modified Health Policy Project (HPP) HIV-Stigma and Discrimination Reduction Training Curriculum
2019
N/A
~810

Find a Location

Who is running the clinical trial?

RTI InternationalLead Sponsor
188 Previous Clinical Trials
875,631 Total Patients Enrolled
SisterLove, Inc.OTHER_GOV
1 Previous Clinical Trials
313 Total Patients Enrolled
Positive Impact Health CentersUNKNOWN
2 Previous Clinical Trials
384 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this study currently seeking participants?

"The information on clinicaltrials.gov confirms that the recruitment period for this experiment has ended; it was originally posted on June 1st 2022 and last updated 8 days later. Fortunately, there are over 1400 other trials which are presently admitting patients."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
The IMPROV Project: Improving Mental Health and Substance Use Treatment Provision (IMPROV) Among People Living With HIV (Human Immunodeficiency Virus) in Atlanta
2022. "The IMPROV Project: Improving Mental Health and Substance Use Treatment Provision (IMPROV) Among People Living With HIV (Human Immunodeficiency Virus) in Atlanta". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05415891.
All > Vision > Hiv
~118 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top